30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Rapport Therapeutics Inc (RAPP)

Track

Over the last 90 days, Rapport Therapeutics Inc. has seen significant insider selling activity, totaling over $73 million. Notably, Third Rock Ventures V, L.P., a 10% stockholder, has been involved in numerous large proposed and planned sales. Other executives also participated in planned sales, contributing to the overall net selling trend.
Stock chart
Ticker: RAPP Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Third Rock Ventures V, L.P.
2 sales — total 1,486,633 USD
Planned sale 26 May 2026
Value US$2,527,846.73 | Price 132.56 | Shares 37,434
Proposed sale 26 May 2026
Value US$2,812,386.80 | Price 192.88 | Shares 74,555
Planned sale 11 May 2026
Value US$3,268,804.28 | Price 456.79 | Shares 21,561
Proposed sale 11 May 2026
Value US$869,709.88 | Price 101.75 | Shares 18,266
Planned sale 8 May 2026
Value US$202,255.51 | Price 40.31 | Shares 5,018
Proposed sale 8 May 2026
Value US$202,254.50 | Price 40.31 | Shares 5,018
Proposed sale 8 May 2026
Value US$202,254.50 | Price 40.31 | Shares 5,018
Planned sale 7 May 2026
Value US$10,892,650.90 | Price 40.12 | Shares 271,495
Proposed sale 7 May 2026
Value US$10,892,705.19 | Price 40.12 | Shares 271,495
Planned sale 17 Apr 2026
Value US$17,175,243.58 | Price 40.32 | Shares 426,005
Proposed sale 17 Apr 2026
Value US$17,175,115.78 | Price 40.32 | Shares 426,005
Planned sale 17 Apr 2026
Value US$808,844.27 | Price 39.99 | Shares 20,225
Proposed sale 17 Apr 2026
Value US$799,696.50 | Price 39.54 | Shares 20,225
Planned sale 14 Apr 2026
Value US$357,796.62 | Price 35.08 | Shares 10,200
Planned sale 13 Apr 2026
Value US$320,536.71 | Price 34.97 | Shares 9,165
Proposed sale 13 Apr 2026
Value US$661,702.05 | Price 34.17 | Shares 19,365
Planned sale 10 Apr 2026
Value US$17,490.00 | Price 34.98 | Shares 500
Proposed sale 10 Apr 2026
Value US$17,110.00 | Price 34.22 | Shares 500
Planned sale 8 Apr 2026
Value US$12,564.00 | Price 34.90 | Shares 360
Proposed sale 8 Apr 2026
Value US$12,056.40 | Price 33.49 | Shares 360
Planned sale 30 Mar 2026
Value US$81,061.97 | Price 28.55 | Shares 2,839
Planned sale 30 Mar 2026
Value US$200,795.16 | Price 28.04 | Shares 7,161
Proposed sale 30 Mar 2026
Value US$278,400.00 | Price 27.84 | Shares 10,000
Planned sale 25 Mar 2026
Value US$303,354.92 | Price 29.99 | Shares 10,115
Proposed sale 25 Mar 2026
Value US$285,748.75 | Price 28.25 | Shares 10,115
Sale 5 Mar 2026
Value US$58,265.02 | Price 28.93 | Shares 2,014
Proposed sale 5 Mar 2026
Value US$58,236.21 | Price 28.92 | Shares 2,014
Planned sale 18 Feb 2026
Value US$62,572.65 | Price 29.80 | Shares 2,100
Planned sale 18 Feb 2026
Value US$86,639.15 | Price 29.04 | Shares 2,983
Planned sale 18 Feb 2026
Value US$67,969.92 | Price 29.80 | Shares 2,281
Planned sale 18 Feb 2026
Value US$103,191.28 | Price 29.05 | Shares 3,552
Planned sale 17 Feb 2026
Value US$65,107.68 | Price 29.59 | Shares 2,200
Planned sale 17 Feb 2026
Value US$156,328.38 | Price 28.95 | Shares 5,400
Planned sale 17 Feb 2026
Value US$25,218.99 | Price 28.02 | Shares 900
Planned sale 20 Jan 2026
Value US$132,737.46 | Price 26.11 | Shares 5,083
Planned sale 20 Jan 2026
Value US$152,333.46 | Price 26.12 | Shares 5,833
Planned sale 15 Jan 2026
Value US$5,480.00 | Price 27.40 | Shares 200
Planned sale 15 Jan 2026
Value US$222,651.65 | Price 26.83 | Shares 8,300
Proposed sale 15 Jan 2026
Value US$466,140.00 | Price 27.42 | Shares 17,000
Proposed sale 2 Jan 2026
Value US$197,337.69 | Price 30.05 | Shares 6,567
Proposed sale 2 Jan 2026
Value US$85,342.57 | Price 30.05 | Shares 2,840
Sale 31 Dec 2025
Value US$197,337.69 | Price 30.05 | Shares 6,567
Sale 31 Dec 2025
Value US$85,342.00 | Price 30.05 | Shares 2,840
Planned sale 17 Dec 2025
Value US$15,985.39 | Price 31.04 | Shares 515
Planned sale 17 Dec 2025
Value US$72,721.51 | Price 30.04 | Shares 2,421
Planned sale 17 Dec 2025
Value US$61,924.85 | Price 28.84 | Shares 2,147
Planned sale 17 Dec 2025
Value US$18,621.60 | Price 31.04 | Shares 600
Planned sale 17 Dec 2025
Value US$83,861.91 | Price 30.04 | Shares 2,792
Planned sale 17 Dec 2025
Value US$70,393.07 | Price 28.84 | Shares 2,441
Proposed sale 17 Dec 2025
Value US$469,059.24 | Price 30.76 | Shares 15,249
Proposed sale 17 Dec 2025
Value US$538,269.24 | Price 30.76 | Shares 17,499
Planned sale 15 Dec 2025
Value US$24,419.05 | Price 30.68 | Shares 796
Planned sale 15 Dec 2025
Value US$230,710.92 | Price 29.95 | Shares 7,704
Planned sale 26 Nov 2025
Value US$150,486.50 | Price 30.10 | Shares 5,000
Planned sale 17 Nov 2025
Value US$135,695.92 | Price 25.39 | Shares 5,344
Planned sale 17 Nov 2025
Value US$78,394.72 | Price 24.84 | Shares 3,156
Planned sale 17 Nov 2025
Value US$72,266.52 | Price 25.44 | Shares 2,841
Planned sale 17 Nov 2025
Value US$55,849.79 | Price 24.91 | Shares 2,242
Planned sale 17 Nov 2025
Value US$77,715.00 | Price 25.43 | Shares 3,056
Planned sale 17 Nov 2025
Value US$69,215.61 | Price 24.92 | Shares 2,777
Planned sale 15 Oct 2025
Value US$19,759.94 | Price 26.17 | Shares 755
Planned sale 15 Oct 2025
Value US$111,428.69 | Price 25.75 | Shares 4,328
Planned sale 15 Oct 2025
Value US$31,001.09 | Price 26.14 | Shares 1,186
Planned sale 15 Oct 2025
Value US$119,539.43 | Price 25.72 | Shares 4,647
Planned sale 15 Oct 2025
Value US$28,309.56 | Price 26.16 | Shares 1,082
Planned sale 15 Oct 2025
Value US$190,886.65 | Price 25.73 | Shares 7,418
Proposed sale 15 Oct 2025
Value US$634,440.00 | Price 24.88 | Shares 25,500
Planned sale 17 Sep 2025
Value US$18,930.03 | Price 27.04 | Shares 700
Planned sale 17 Sep 2025
Value US$917,541.78 | Price 26.30 | Shares 34,885
Planned sale 17 Sep 2025
Value US$37,624.30 | Price 26.87 | Shares 1,400
Planned sale 17 Sep 2025
Value US$1,037,101.06 | Price 26.30 | Shares 39,435
Proposed sale 17 Sep 2025
Value US$1,375,001.19 | Price 26.19 | Shares 52,501
Proposed sale 17 Sep 2025
Value US$1,198,218.69 | Price 26.19 | Shares 45,751
Planned sale 15 Sep 2025
Value US$83,887.54 | Price 24.66 | Shares 3,402
Planned sale 15 Sep 2025
Value US$121,761.14 | Price 23.88 | Shares 5,098
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-28 2026-05-26 PlS Planned sale
3.2
Third Rock Ventures V, L.P.
Large shareholder
37,434 +3.1%
132.56
US$2,527,847 		37,434 +3.1% 132.56 US$2,527,847
2026-05-27 2026-05-26 PrS Proposed sale
3.2
Third Rock Ventures V, L.P.

10% Stockholder

Large shareholder
74,555
192.88
US$2,812,387 		74,555 192.88 US$2,812,387
2026-05-13 2026-05-11 PlS Planned sale
3.2
Third Rock Ventures V, L.P.
Large shareholder
21,561 -25.3%
456.79
US$3,268,804 		21,561 -25.3% 456.79 US$3,268,804
2026-05-11 2026-05-11 PrS Proposed sale
3.2
Third Rock Ventures V, L.P.

10% Stockholder

Large shareholder
133,618
40.25
US$5,378,124 		133,618 40.25 US$5,378,124
2026-05-11 2026-05-08 PlS Planned sale
3.2
Third Rock Ventures V, L.P.
Large shareholder
5,018 -0.1%
40.31
US$202,256 		5,018 -0.1% 40.31 US$202,256
2026-05-08 2026-05-08 PrS Proposed sale
3.2
Third Rock Ventures V, L.P.

10% Stockholder

Large shareholder
5,018
40.31
US$202,254 		5,018 40.31 US$202,254
2026-05-08 2026-05-08 PrS Proposed sale
3.2
Third Rock Ventures V, L.P.

10% Stockholder

Large shareholder
5,018
40.31
US$202,254 		5,018 40.31 US$202,254
2026-05-11 2026-05-07 PlS Planned sale
3.2
Third Rock Ventures V, L.P.
Large shareholder
271,495 -4.0%
40.12
US$10,892,651 		271,495 -4.0% 40.12 US$10,892,651
2026-05-07 2026-05-07 PrS Proposed sale
3.2
Third Rock Ventures V, L.P.

10% Stockholder

Large shareholder
271,495
40.12
US$10,892,705 		271,495 40.12 US$10,892,705
2026-04-21 2026-04-17 PlS Planned sale
3.2
Third Rock Ventures V, L.P.
Large shareholder
426,005 -6.0%
40.32
US$17,175,244 		426,005 -6.0% 40.32 US$17,175,244
2026-04-21 2026-04-17 PlS Planned sale
1.7
Yeleswaram Krishnaswamy

Chief Development Officer

Officer
20,225 -7.6%
39.99
US$808,844 		20,225 -7.6% 39.99 US$808,844
2026-04-17 2026-04-17 PrS Proposed sale
1.7
KRISHNASWAMY YELESWARAM

Officer

Officer
20,225
39.54
US$799,696 		20,225 39.54 US$799,696
2026-04-17 2026-04-17 PrS Proposed sale
3.2
Third Rock Ventures V, L.P.

10% Stockholder

Large shareholder
426,005
40.32
US$17,175,116 		426,005 40.32 US$17,175,116
2026-04-14 2026-04-14 PlS Planned sale
1.7
Yeleswaram Krishnaswamy

Chief Development Officer

Officer
10,200 -3.7%
35.08
US$357,797 		10,200 -3.7% 35.08 US$357,797
2026-04-14 2026-04-13 PlS Planned sale
1.7
Yeleswaram Krishnaswamy

Chief Development Officer

Officer
9,165 -3.2%
34.97
US$320,537 		9,165 -3.2% 34.97 US$320,537
2026-04-13 2026-04-13 PrS Proposed sale
1.7
KRISHNASWAMY YELESWARAM

Officer

Officer
19,365
34.17
US$661,702 		19,365 34.17 US$661,702
2026-04-14 2026-04-10 PlS Planned sale
1.7
Yeleswaram Krishnaswamy

Chief Development Officer

Officer
500 -0.2%
34.98
US$17,490 		500 -0.2% 34.98 US$17,490
2026-04-10 2026-04-10 PrS Proposed sale
1.7
KRISHNASWAMY YELESWARAM

Officer

Officer
500
34.22
US$17,110 		500 34.22 US$17,110
2026-04-09 2026-04-08 PlS Planned sale
1.7
Yeleswaram Krishnaswamy

Chief Development Officer

Officer
360 -0.1%
34.90
US$12,564 		360 -0.1% 34.90 US$12,564
2026-04-08 2026-04-08 PrS Proposed sale
1.7
KRISHNASWAMY YELESWARAM

Officer

Officer
360
33.49
US$12,056 		360 33.49 US$12,056
2026-03-31 2026-03-30 PlS Planned sale
Gault Cheryl

Chief Operating Officer

Officer
2,839 -1.7%
28.55
US$81,062 		2,839 -1.7% 28.55 US$81,062
2026-03-31 2026-03-30 PlS Planned sale
Gault Cheryl

Chief Operating Officer

Officer
7,161 -4.2%
28.04
US$200,795 		7,161 -4.2% 28.04 US$200,795
2026-03-30 2026-03-30 PrS Proposed sale
CHERYL GAULT

Officer

Officer
10,000
27.84
US$278,400 		10,000 27.84 US$278,400
2026-03-26 2026-03-25 PlS Planned sale
1.7
Yeleswaram Krishnaswamy

Chief Development Officer

Officer
10,115 -3.4%
29.99
US$303,355 		10,115 -3.4% 29.99 US$303,355
2026-03-25 2026-03-25 PrS Proposed sale
1.7
KRISHNASWAMY YELESWARAM

Officer

Officer
10,115
28.25
US$285,749 		10,115 28.25 US$285,749
2026-03-09 2026-03-05 S Sale
Gault Cheryl

Chief Operating Officer

Officer
2,014 -1.2%
28.93
US$58,265 		2,014 -1.2% 28.93 US$58,265
2026-03-05 2026-03-05 PrS Proposed sale
Gault Cheryl

Officer

Officer
2,014
28.92
US$58,236 		2,014 28.92 US$58,236
2026-02-19 2026-02-18 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
2,100 -9.2%
29.80
US$62,573 		2,100 -9.2% 29.80 US$62,573
2026-02-19 2026-02-18 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
2,983 -11.6%
29.04
US$86,639 		2,983 -11.6% 29.04 US$86,639
2026-02-19 2026-02-18 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
2,281 -0.4%
29.80
US$67,970 		2,281 -0.4% 29.80 US$67,970
2026-02-19 2026-02-18 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
3,552 -0.6%
29.05
US$103,191 		3,552 -0.6% 29.05 US$103,191
2026-02-19 2026-02-17 PlS Planned sale
1.7
Bredt David

Chief Scientific Officer

Officer
2,200 -0.6%
29.59
US$65,108 		2,200 -0.6% 29.59 US$65,108
2026-02-19 2026-02-17 PlS Planned sale
1.7
Bredt David

Chief Scientific Officer

Officer
5,400 -1.4%
28.95
US$156,328 		5,400 -1.4% 28.95 US$156,328
2026-02-19 2026-02-17 PlS Planned sale
1.7
Bredt David

Chief Scientific Officer

Officer
900 -0.2%
28.02
US$25,219 		900 -0.2% 28.02 US$25,219
2026-01-22 2026-01-20 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
5,083 -16.5%
26.11
US$132,737 		5,083 -16.5% 26.11 US$132,737
2026-01-22 2026-01-20 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
5,833 -1.0%
26.12
US$152,333 		5,833 -1.0% 26.12 US$152,333
2026-01-16 2026-01-15 PlS Planned sale
1.7
Bredt David

Chief Scientific Officer

Officer
200 -0.1%
27.40
US$5,480 		200 -0.1% 27.40 US$5,480
2026-01-16 2026-01-15 PlS Planned sale
1.7
Bredt David

Chief Scientific Officer

Officer
8,300 -2.1%
26.83
US$222,652 		8,300 -2.1% 26.83 US$222,652
2026-01-15 2026-01-15 PrS Proposed sale
1.7
DAVID BREDT

Officer

Officer
17,000
27.42
US$466,140 		17,000 27.42 US$466,140
2026-01-02 2026-01-02 PrS Proposed sale
1.7
DAVID BREDT

Officer

Officer
6,567
30.05
US$197,338 		6,567 30.05 US$197,338
2026-01-02 2026-01-02 PrS Proposed sale
1.7
Krishnaswamy Yeleswaram

Officer

Officer
2,840
30.05
US$85,343 		2,840 30.05 US$85,343
2026-01-05 2025-12-31 S Sale
1.7
Bredt David

Chief Scientific Officer

Officer
6,567 -1.6%
30.05
US$197,338 		6,567 -1.6% 30.05 US$197,338
2026-01-05 2025-12-31 S Sale
1.7
Yeleswaram Krishnaswamy

Chief Development Officer

Officer
2,840 -0.9%
30.05
US$85,342 		2,840 -0.9% 30.05 US$85,342
2025-12-18 2025-12-17 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
515 -1.6%
31.04
US$15,985 		515 -1.6% 31.04 US$15,985
2025-12-18 2025-12-17 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
2,421 -7.2%
30.04
US$72,722 		2,421 -7.2% 30.04 US$72,722
2025-12-18 2025-12-17 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
2,147 -6.0%
28.84
US$61,925 		2,147 -6.0% 28.84 US$61,925
2025-12-18 2025-12-17 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
600 -0.1%
31.04
US$18,622 		600 -0.1% 31.04 US$18,622
2025-12-18 2025-12-17 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
2,792 -0.5%
30.04
US$83,862 		2,792 -0.5% 30.04 US$83,862
2025-12-18 2025-12-17 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
2,441 -0.4%
28.84
US$70,393 		2,441 -0.4% 28.84 US$70,393
2025-12-17 2025-12-17 PrS Proposed sale
THE DOROTHY CEESAY IRREVOCABLE TRUST

Director; Officer

Executive Director
15,249
30.76
US$469,059 		15,249 30.76 US$469,059
2025-12-17 2025-12-17 PrS Proposed sale
ABRAHAM CEESAY

Director; Officer

Executive Director
17,499
30.76
US$538,269 		17,499 30.76 US$538,269
2025-12-16 2025-12-15 PlS Planned sale
1.7
Bredt David

Chief Scientific Officer

Officer
796 -0.2%
30.68
US$24,419 		796 -0.2% 30.68 US$24,419
2025-12-16 2025-12-15 PlS Planned sale
1.7
Bredt David

Chief Scientific Officer

Officer
7,704 -1.9%
29.95
US$230,711 		7,704 -1.9% 29.95 US$230,711
2025-12-01 2025-11-26 PlS Planned sale
Gault Cheryl

Chief Operating Officer

Officer
5,000 -2.8%
30.10
US$150,486 		5,000 -2.8% 30.10 US$150,486
2025-11-18 2025-11-17 PlS Planned sale
1.7
Bredt David

Chief Scientific Officer

Officer
5,344 -1.3%
25.39
US$135,696 		5,344 -1.3% 25.39 US$135,696
2025-11-18 2025-11-17 PlS Planned sale
1.7
Bredt David

Chief Scientific Officer

Officer
3,156 -0.8%
24.84
US$78,395 		3,156 -0.8% 24.84 US$78,395
2025-11-18 2025-11-17 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
2,841 -7.3%
25.44
US$72,267 		2,841 -7.3% 25.44 US$72,267
2025-11-18 2025-11-17 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
2,242 -5.5%
24.91
US$55,850 		2,242 -5.5% 24.91 US$55,850
2025-11-18 2025-11-17 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
3,056 -0.5%
25.43
US$77,715 		3,056 -0.5% 25.43 US$77,715
2025-11-18 2025-11-17 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
2,777 -0.5%
24.92
US$69,216 		2,777 -0.5% 24.92 US$69,216
2025-10-16 2025-10-15 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
755 -1.8%
26.17
US$19,760 		755 -1.8% 26.17 US$19,760
2025-10-16 2025-10-15 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
4,328 -9.4%
25.75
US$111,429 		4,328 -9.4% 25.75 US$111,429
2025-10-16 2025-10-15 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
1,186 -0.2%
26.14
US$31,001 		1,186 -0.2% 26.14 US$31,001
2025-10-16 2025-10-15 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
4,647 -0.8%
25.72
US$119,539 		4,647 -0.8% 25.72 US$119,539
2025-10-16 2025-10-15 PlS Planned sale
1.7
Bredt David

Chief Scientific Officer

Officer
1,082 -0.3%
26.16
US$28,310 		1,082 -0.3% 26.16 US$28,310
2025-10-16 2025-10-15 PlS Planned sale
1.7
Bredt David

Chief Scientific Officer

Officer
7,418 -1.8%
25.73
US$190,887 		7,418 -1.8% 25.73 US$190,887
2025-10-15 2025-10-15 PrS Proposed sale
1.7
DAVID BREDT

Officer

Officer
25,500
24.88
US$634,440 		25,500 24.88 US$634,440
2025-09-19 2025-09-17 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
700 -1.5%
27.04
US$18,930 		700 -1.5% 27.04 US$18,930
2025-09-19 2025-09-17 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
34,885 -42.7%
26.30
US$917,542 		34,885 -42.7% 26.30 US$917,542
2025-09-19 2025-09-17 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
1,400 -0.2%
26.87
US$37,624 		1,400 -0.2% 26.87 US$37,624
2025-09-19 2025-09-17 PlS Planned sale
Ceesay Abraham

Chief Executive Officer

Executive Director
39,435 -6.3%
26.30
US$1,037,101 		39,435 -6.3% 26.30 US$1,037,101
2025-09-17 2025-09-17 PrS Proposed sale
ABRAHAM CEESAY

Director; Officer

Executive Director
52,501
26.19
US$1,375,001 		52,501 26.19 US$1,375,001
2025-09-17 2025-09-17 PrS Proposed sale
THE DOROTHY CEESAY IRREV TRUST U/ADTD 03/27/2024

Director; Officer

Executive Director
45,751
26.19
US$1,198,219 		45,751 26.19 US$1,198,219
2025-09-17 2025-09-15 PlS Planned sale
1.7
Bredt David

Chief Scientific Officer

Officer
3,402 -0.8%
24.66
US$83,888 		3,402 -0.8% 24.66 US$83,888
2025-09-17 2025-09-15 PlS Planned sale
1.7
Bredt David

Chief Scientific Officer

Officer
5,098 -1.2%
23.88
US$121,761 		5,098 -1.2% 23.88 US$121,761
Explore more

More insider trading research around Rapport Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America